The first Neue Klasse BMW offers up an exciting take on the well-trodden SUV path - is the IX3 a sign of what's to come?

Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...

Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...

This paper presents an important advance in genetically encoded voltage imaging of the developing zebrafish spinal cord in vivo, capturing voltage dynamics in neuronal populations, single cells, and ...

Red light range: Pay attention to the wavelengthsred light typically falls between 630660 nanometers, while near-infrared is usually around 830 nanometers, says Dr. Henry. Look for masks that fall ...

While “staffing your company” is imperative and often emphasized, many commanders centralize critical information, leading to ...

Unbelievable – who would have thought it? Last week, silver reached the USD 64 per ounce level for the first time, reflecting ...

Imagine if our bodies could grow new organs throughout our entire lives. Plants do this constantly, thanks to tiny, powerful ...

The bean-shaped organelles are now being recognized for their part in immune signaling, stress responses, and neural ...

A growing number of new studies have found that, at least for some cells, death isn’t the end, but the beginning of something wholly unexpected.

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Amicus Therapeutics (Nasdaq: FOLD) announced today that BioMarin has entered into a definitive agreement to acquire Amicus for $14.50 per share in an ...